Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12577300 | Neutralizing antibodies to human endothelin | 🖼🧊📄§ | 2026-03-17 | 2041-12-20 | 0 | 31 |
| 12576150 | CD4+ T cells expressing IL-10 and chimeric antigen receptors and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2045-02-26 | 0 | 31 |
| 12577312 | Methods for the treatment of melanoma using compositions of denosumab and PD-1 inhibitor | 🖼🧊📄§ | 2026-03-17 | 2045-02-26 | 0 | 31 |
| 12576147 | Recombinant proteins with CD40 activating properties | 🖼🧊📄§ | 2026-03-17 | 2040-03-26 | 0 | 31 |
| 12576070 | Medicine for improving state of pregnancy, and use thereof | 🖼🧊📄§ | 2026-03-17 | 2042-11-23 | 0 | 31 |
| 12576136 | Insulin derivative | 🖼🧊📄§ | 2026-03-17 | 2040-12-29 | 0 | 31 |
| 12576045 | Methods and nutraceutical compositions for the prevention and/or mitigation of veisalgia | 🖼🧊📄§ | 2026-03-17 | 2043-02-06 | 0 | 31 |
| 12576158 | Antibody drug conjugates with cleavable linkers | 🖼🧊📄§ | 2026-03-17 | 2040-05-22 | 0 | 31 |
| 12577309 | Anti-CSF1R molecules and use thereof | 🖼🧊📄§ | 2026-03-17 | 2040-12-23 | 0 | 31 |
| 12576094 | Combination cannabinoid-phenylethanoid formulation for treatment of inflammation and methods related thereto | 🖼🧊📄§ | 2026-03-17 | 2040-11-20 | 0 | 31 |
| 12576111 | Application of BMSC-exos in treating PD | 🖼🧊📄§ | 2026-03-17 | 2042-10-19 | 0 | 31 |
| 12576084 | Methods for treating testicular and ovarian adrenal rest tumors | 🖼🧊📄§ | 2026-03-17 | 2045-01-31 | 0 | 31 |
| 12576130 | Dominant negative SARM1 molecules comprising a substitution at position 189, 190, 193, 194, 570 and/or 685 of SARM1 | 🖼🧊📄§ | 2026-03-17 | 2038-10-18 | 0 | 31 |
| 12576123 | Epitope-based approach for allergy treatments and inhibitors for Crohn's disease | 🖼🧊📄§ | 2026-03-17 | 2040-03-13 | 0 | 31 |
| 12577267 | Pyrimidine compounds for use as MAP4K1 inhibitors | 🖼🧊📄§ | 2026-03-17 | 2042-07-06 | 0 | 31 |
| 12577323 | Compositions and conjugates comprising an interleukin and polypeptides that specifically bind TGF-beta | 🖼🧊📄§ | 2026-03-17 | 2036-06-08 | 0 | 31 |
| 12576059 | Methods and compositions for treatment of inflammatory disease | 🖼🧊📄§ | 2026-03-17 | 2044-03-21 | 0 | 31 |
| 12576128 | Genetically engineered microorganisms and methods of use | 🖼🧊📄§ | 2026-03-17 | 2040-05-01 | 0 | 31 |
| 12576191 | Method of inducing cardiomyocytes proliferation and treating heart diseases | 🖼🧊📄§ | 2026-03-17 | 2043-09-14 | 0 | 31 |
| 12576077 | Composition for preventing, alleviating or treating cancer | 🖼🧊📄§ | 2026-03-17 | 2043-08-28 | 0 | 31 |
| 12580049 | Tumor microenvironment-based methods for assessing CAR-T and other immunotherapies | 🖼🧊📄§ | 2026-03-17 | 2042-12-23 | 0 | 31 |
| 12576140 | Cyclophilin 40 for reduction of neurotoxic fibrils and treatment of neurodegenerative diseases | 🖼🧊📄§ | 2026-03-17 | 2041-07-29 | 0 | 31 |
| 12576040 | Ionizable lipids and methods of manufacture and use thereof | 🖼🧊📄§ | 2026-03-17 | 2041-10-13 | 0 | 31 |
| 12577282 | Galectin-1/ galectin-3 chimeras and multivalent proteins | 🖼🧊📄§ | 2026-03-17 | 2040-02-28 | 0 | 31 |
| 12577287 | T cell receptors and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2040-03-24 | 0 | 31 |
| 12576155 | Senolytic and antiinflammatory prodrugs and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2040-09-24 | 0 | 31 |
| 12576134 | Antiviral lectin and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2039-09-06 | 0 | 31 |
| 12576055 | Disease detection and treatment based on trimethyl-lysine levels | 🖼🧊📄§ | 2026-03-17 | 2039-02-01 | 0 | 31 |
| 12576096 | Topical, isotonic compositions for genital use | 🖼🧊📄§ | 2026-03-17 | 2041-06-09 | 0 | 31 |
| 12577290 | FasL expression and FasR gene knockout to protect therapeutic cells from allogeneic rejection and activation-induced cell death | 🖼🧊📄§ | 2026-03-17 | 2042-03-04 | 0 | 31 |
| 12577318 | Humanized anti-CA IX antibodies and methods of their use | 🖼🧊📄§ | 2026-03-17 | 2039-11-05 | 0 | 31 |
| 12576047 | Telomerase activating compounds for use in fertility and related applications | 🖼🧊📄§ | 2026-03-17 | 2043-08-25 | 0 | 31 |
| 12576075 | Combination therapies for treating cancer | 🖼🧊📄§ | 2026-03-17 | 2039-10-30 | 0 | 31 |
| 12576098 | Saponin containing extracts prepared from Hesperaloe useful in the treatment of non-human animals | 🖼🧊📄§ | 2026-03-17 | 2041-06-21 | 0 | 31 |
| 12576139 | Method and drug for treating spinal muscular atrophy | 🖼🧊📄§ | 2026-03-17 | 2040-11-17 | 0 | 31 |
| 12576067 | Methods and compositions for treatment of mydriasis | 🖼🧊📄§ | 2026-03-17 | 2045-01-17 | 0 | 31 |
| 12576151 | Fratricide resistant modified immune cells and methods of using the same | 🖼🧊📄§ | 2026-03-17 | 2041-09-24 | 0 | 31 |
| 12576088 | Methods for enhancing cytotoxic cancer therapy through inhibition of ATG4B | 🖼🧊📄§ | 2026-03-17 | 2043-09-15 | 0 | 31 |
| 12577280 | Glycosylated comp pilin variants, methods of making and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2044-03-14 | 0 | 31 |
| 12576024 | Compositions comprising Propionibacterium acnes bacteriophages for treating acne | 🖼🧊📄§ | 2026-03-17 | 2044-01-16 | 0 | 31 |
| 12577298 | Anti-IL-5 antibodies | 🖼🧊📄§ | 2026-03-17 | 2041-07-26 | 0 | 31 |
| 12577305 | Multispecific antigen binding proteins capable of binding CD19 and CD3, and use thereof | 🖼🧊📄§ | 2026-03-17 | 2039-12-23 | 0 | 31 |
| 12576118 | Bacteriophages for the treatment of tuberculosis | 🖼🧊📄§ | 2026-03-17 | 2040-05-21 | 0 | 31 |
| 12577325 | Bispecific antibody-camptothecin drug conjugate and pharmaceutical use thereof | 🖼🧊📄§ | 2026-03-17 | 2044-11-22 | 0 | 31 |
| 12576053 | Use of 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl) methylidenejinden-1-yl] acetic acid | 🖼🧊📄§ | 2026-03-17 | 2038-04-11 | 0 | 31 |
| 12576061 | Agent for inducing regression of triglyceride deposit atherosclerosis | 🖼🧊📄§ | 2026-03-17 | 2041-03-05 | 0 | 31 |
| 12576069 | Compositions and methods for treating slow-flow vascular malformations | 🖼🧊📄§ | 2026-03-17 | 2040-09-10 | 0 | 31 |
| 12576078 | Compounds and combinations thereof for treating neurological and psychiatric conditions | 🖼🧊📄§ | 2026-03-17 | 2045-04-17 | 0 | 31 |
| 12577208 | TEAD inhibitors and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2043-06-16 | 0 | 31 |
| 12576081 | Methods and compositions for improving exercise performance, single ventricular performance, cardiac output and myocardial performance index (MPI) in single ventricular heart disease, using udenafil compositions | 🖼🧊📄§ | 2026-03-17 | 2040-07-24 | 0 | 31 |